经尿道绿激光汽化术联合汽化电切术治疗重度前列腺增生的临床研究

于正刚; 李健; 冯起庆

经尿道绿激光汽化术联合汽化电切术治疗重度前列腺增生的临床研究

- 1 天津市人民医院泌尿外科(天津, 300121)

详细信息

通讯作者: 李健,E-mail:Lijian_umc@sina.com

中图分类号: R697

收稿日期: 2011-11-11

The clinical study of greenlight photoselective vaporization of prostate joint transurethral electrovaporization resection of prostate in the treatment of severe benign prostatic hyperplasia

- Department of Urology, Tianjin People`s Hospital, Tianjin, 300121, China

More Information

Corresponding author: LI Jian, E-mail: Lijian_umc@sina.com

Received Date: 11 November 2011

摘要

摘要: 目的:评估经尿道前列腺选择性绿激光汽化术联合汽化电切术(PVP+TUVP)与经尿道前列腺汽化电切术(TUVP)治疗体积大于80 ml重度BPH的安全性和临床疗效。方法:选取符合入选标准的重度BPH患者95例,按手术方式随机分为PVP+TUVP治疗组48例和TUVP对照组47例,比较两种术式的手术时间、术中出血量、术后血尿时间、症状评分、尿流动力学及并发症等指标。结果:PVP+TUVP组手术时间略长于TUVP组,但差异无统计学意义(P>0.10)。PVP+TUVP组术中出血量、术后血尿时间、并发症均少于TUVP组,差异有统计学意义(P<0.05)。术后随访12个月,PVP+TUVP组IPSS评分、QOL评分、Q_max、RUV均比术前明显改善(P<0.002),但组间比较差异无统计学意义(P>0.05)。结论:对于体积大于80 ml重度BPH患者,PVP+TUVP比TUVP具有术中风险低、术后恢复快和并发症少等优点,临床疗效相似,是一种更加安全有效的微创手术方式。
- 重度前列腺增生 /
- 前列腺选择性绿激光汽化术 /
- 经尿道前列腺汽化电切术
Abstract: Objective:To evaluate safety and clinical efficacy of greenlight photoselective vaporization of prostate joint transurethral electrovaporization resection of prostate (PVP + TUVP) and transurethral electrovaporization resection of prostate (TUVP) treating volume greater than 80ml severe benign prostatic hyperplasia (BPH). Methods:Selected met the inclusion criteria severe benign prostatic hyperplasia patients with 95 cases, according to surgical treatment were randomly divided into PVP + TUVP group of 48 cases and TUVP control group of 47 patients, comparing two surgical operation time, blood loss, postoperative hematuria time, symptom score, urodynamic and complications indicators. Results:PVP + TUVP operative time was slightly longer than TUVP group, but the difference was not statistically significant (P>0.10). PVP + TUVP group blood loss, postoperative hematuria time and complications are superior to TUVP group, the difference was statistically significant (P<0.05). Patients were followed up for 12 months, PVP + TUVP group of international prostate symptom score (IPSS), quality of life score (QOL), maximum urinary flow rate (Q_max) and bladder residual urine (RUV) than before surgery significantly improved (P< 0.002), but two of these indicators was no significant difference (P>0.05). Conclusions:For volumes greater than 80ml severe BPH patients, PVP+TUVP than TUVP with low-risk surgery, rapid postoperative recovery and fewer complications, similar to clinical efficacy,it is a more safe and effective minimally invasive surgical approach.
- severe benign prostatic hyperplasia /
- photoselective vaporization of prostate /
- transurethral electrovaporization resection of prostate

HTML全文

参考文献(9)

[1]	BERGER A P,WIRTENBERGER W,BEKTIC J,etal.Safer transurethral resection of the prostate:coag-ulating intermittent cutting reduces haemostatic com-plications[J].J Urol,2004,171:289.
[2]	吴阶平主编.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2008:1141-1155.
[3]	庄花元主编.经尿道手术学[M].武汉:湖北科学技术出版社,2002:135-156.
[4]	BOUCHIER HAYES D M,VAN APPLEDORN S,BUGEJA P,et al.A randomized trial of photoselec-tive vaporization of the prostate using the 80Wpotas-sium-titanyl-phosphate laser vs transurethral prosta-tectomy,with a 1-year follow-up[J].BJU Interna-tional,2010,105:964-969.
[5]	GILLING P J,CASS C B,MALCOLM A R,et al.Combination holmium and Nd:YAG laser ablation ofthe prostate:Initial clinical experience[J].J Endou-rol,1995,9:151-153.
[6]	REICH O,BACHMANN A,SIEBELS M,et al.High power(80W)potassium titanyl phosphate laservaporization of the prostate in 66high risk patients[J].J Urol,2005,173:158-160.
[7]	BARBER N J,ZHU G,DONOHUE J F,et al.Use ofexpired breath ethanol measurements in evaluation ofirrigant absorption during llighpower potassium tita-nyl phosphate laser vaporization 0fprostate[J].Urol-ogy,2006,67:80-83.
[8]	郭征,刘锋,姬西宁,等.选择性光前列腺汽化术和经尿道前列腺电切治疗良性前列腺增生术后阴茎勃起功能影响的比较[J].中国现代医学杂志,2008,18(15):2240-2244.
[9]	TE A E,MALLOY T R,STEIN B S,et al.Photoselective vaporization of the prostate for the treatmentof benign prostatic hyperplasia;12-month results fromthe first United States multicenter prospective trial[J].J Uorl,2004,172:1404-1408.